Friday, January 11, 2013

Clinical trials essential in fighting mesothelioma

Clinical trials helpful in fighting mesothelioma

The National Institutes of Health reveals that clinical trial is essential for a patient’s medical advances. “Clinical trials serve to uncover better ways to treat, prevent, diagnose and understand human disease,” reports Mesothelioma Help. But what’s even better is that getting cleaning trials at the onset of mesothelioma cancer will do so much to help researchers obtain the necessary information information needed to push through with their studies in providing cure to this seemingly incurable disease.


Mesothelioma is a very destructive form of cancer that stems from excessive exposure to asbestos. Unlike other types of cancer, it is resistant to conventional treatment. However, this medical dead-end only serves to double the efforts of scientists and researchers in looking for an effective treatment. In fact, clinical trials are conducted in all 60 states and in almost 200 countries around the world. These activities are “managed through Clinicaltrials.gov,” a the national database of “clinical trials information for both federally and privately funded trials.” To date, more than 50 open studies are conducted, which focus on malignant mesothelioma. Trial are conducted in the US, UK, Canada, Belgium, Israel, Germany and Italy.

One obstacle however is the lack of patients to enter trials.  In the U.S. alone, a study reveals that less than 5% of the over 10 million cancer-inflicted adults are willing to participate in clinical trials. The NIH confesses that the lack of volunteers directly hampers the studies. Either these people lack the awareness on the benefits of the studies or they do not have the confidence on the research. 

But they really don’t have to fear. Clinical trials are performed on strict supervision and run according “to strict guidelines.”  According to NIH, “federally funded clinical research has safeguards in place to protect the participants,” although it’s really up to patient if he wants to undergo a clinical trial after careful consideration of the benefits and risks entailed.

No comments:

Post a Comment